The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology (한방안이비인후피부과학회지)

The Society of Korean Medicine Ophthalmology, Otolaryngology & Dermatology (대한한방안이비인후피부과학회)
권호 표지
DOI QR코드

DOI QR Code

The Effects of Ethanol Extract from Atractylodes Chinensis Rhizome on the Mast Cell-Mediated Inflammatory Responses

창출(蒼朮) 에탄올 추출물이 비만세포 매개 염증반응에 미치는 영향

  • 김선민 (경원대학교 한의과대학 안이비인후피부과학 교실) ;
  • 김경준 (경원대학교 한의과대학 안이비인후피부과학 교실)
  • Received : 2011.03.08
  • Accepted : 2011.04.05
  • Published : 2011.04.25
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : Atractyloides Chinensis Rhizome (ACR) is widely used in oriental medicine as a remedy for an inflammation and an allergic disease. However, as yet there is no clear explanation of how ACR affects the production of inflammatory cytokine. This study was to determine the effects of ACR on the mast cell-mediated inflammatory responses. Method : The amount of inflammatory cytokine production induced by the phorbol myristate acetate (PMA) plus calcium ionophore(A23187) in the human mast cell line (HMC-1) incubated with various concentrations of ACR was measured. The TNF-${\alpha}$ protein levels were analysised by Western blots. The TNF-${\alpha}$, IL-6 and IL-8 secreted protein levels were measured by the ELISA assay. The TNF-${\alpha}$, IL-6 and IL-8 mRNA levels were measured by the RT-PCR analysis. NF-${\kappa}$B, phospho-I${\kappa}$B and MAPKs were examined by Western blot analysis. The NF-${\kappa}$B promoter activity was examined by a luciferase assay. Results : 1. The expressions of TNF-${\alpha}$ and TNF-${\alpha}$ mRNA were decreased dose-dependently at 0.05-0.2mg/$m\ell$ of ACR and significantly decreased at 0.2mg/$m\ell$. 2. The expressions of IL-6 and IL-6 mRNA were decreased dose-dependently at 0.05-0.2mg/$m\ell$ of ACR and significantly decreased at 0.2mg/$m\ell$. 3. The expressions of IL-8 and IL-8 mRNA were decreased dose-dependently at 0.05-0.2mg/$m\ell$ of ACR and significantly decreased at 0.2mg/$m\ell$ specially. 4. The expressions of Phosphorylated-JNK were decreased, not p38, ERK 5. The expressions of NF-${\kappa}$B were decreased dose-dependently at 0.1-0.2mg/$m\ell$ of ACR. The expressions of Phosphorylated I${\kappa}$B were significantly decreased at 0.2mg/$m\ell$. In addition, ACR suppressed PMA plus A23187-induced NF-${\kappa}$B promoting activity. Conclusion : It is suggested that ACR should suppress through inhibition of NF-${\kappa}$B activity and cytokine production.

Keywords

References

  1. Janeway C. A. Jr., Travers P., Walport M & Shlomchik, M. 면역생물학(Immunobiology 6th edition). 서울:라이프사이언스. 2005:13, 46-7, 78-80, 564-6.
  2. Goldsby, R. A., Kindt, T. J., Osborne, B.A.,& Kuby, J. KUBY 면역학(Kuby immunology). 서울:월드사이언스. 2006:263, 419-20, 398-423, 417-8.
  3. Thomas PS. Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma. Immunol Cell Biol. 2001;79:132-40. https://doi.org/10.1046/j.1440-1711.2001.00980.x
  4. Naka S, Suto H, Kakurai M, Sedgwick JD, Tsai M, Galli SJ. Mast cells enhance T cell activation: importance of mast cell-derived TNF. Proc Natl Acad Sci USA. 2005;102:6467-72. https://doi.org/10.1073/pnas.0501912102
  5. Bodreau RT, Hoskin DW, Lin TJ. Phosphatase inhibition potentiates IL-6 production by mast cells in response to Fcepsilon RI-mediated activation: involvement of p38 MAPK. J Leukoc Biol. 2004;76:1075-81. https://doi.org/10.1189/jlb.1003498
  6. Murayama T, Mukaida N, Sadanari H, Yamaguchi N, Khabar KS, Tanaka J, Matsushima K, Mori S, Eizuru Y. The immediate early gene 1 product of human cytomegalovirus is sufficient for upregulation of interleukin-8 gene expression. Biochem Biophys Res Commun. 2000;279(1):298-304. https://doi.org/10.1006/bbrc.2000.3923
  7. Arbabi S, Maier RV. Mitogen-activated protein kinases. Crit Care Med. 2002;30:74-9.
  8. Beyaert R, Cuenda A, Vanden Berghe W, Plaisance S, Lee JC, Haegeman G, Cohen P, Fiers W. The p38/RK mitogen activat-ed protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J. 1996;15:1914-23.
  9. Kim SH, Choi CH, Kim SY, Eun JS, Shin TY. Anti-allergic effects of Artemisia iwayomogi on mast cell-mediated allergy model. Exp Biol Med (Maywood). 2005;230:82-8.
  10. Kuprsh DV, Udalova IA, Turetskaya RL, Rice NR, Nedospasov SAC. Convserved kappa B element located downstream of the tumor necrosis factor alpha gene: distinct NF-kappa B binding pattern and enhancer activity in LPS activated murine macrophages. Oncogene. 1995;11:97-106.
  11. Galien R, Evans HF, Garcia T. Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding site in interleukin-6 promoter inhibition by estrogens. Mol Endocrinol. 1996;10:713-22. https://doi.org/10.1210/me.10.6.713
  12. 韓醫科大學 本草學 編纂委員會. 本草學. 서울:영림사. 2004;334-5.
  13. 박종찬, 이장천, 국윤범, 염현식, 윤용갑. 方藥合編중 蒼朮이 配伍된 方劑의 活用에 대한 考察. 대한한의학 방제학회지. 2003;11(2):41-60.
  14. 林剛民. 不換金正氣散이 마우스 Th1/Th2 분화 및 알레르기 염증 반응 조절에 미치는 효과. 동의생리병리학회지. 2006;20(6):1467-76.
  15. 한영규, 加味蒼栢散 Carrageenan유발 동물모델 관절염의 소염, 진통, 해열 및 면역에 미치는 영향. 한방재활의학과학회지. 2005;15(1):127-41.
  16. 이정우. 蒼朮이 천식 관련 Th1/Th2 세포분비 cytokine에 미치는 영향. 대한한방내과학회지. 2007;28(4):681-93.
  17. 허인희. 蒼朮 추출물의 BV2 cell 소염작용에 관한 실험적 연구. 대한한방안이비인후피부과학회지. 2007;20(2):36-46.
  18. Hachisuka H, Kusuhara M, Higuchi M, Okubo K, Sasai Y. Purification of rat cutaneous mast cells with Percoll density centrifugation. Arch Dermatol Res. 1988;280:358-62. https://doi.org/10.1007/BF00426614
  19. 이중달. 기본병리학. 서울:고려의학. 1996;79-130.
  20. 강병수. 韓方臨床 알레르기, 서울:성보사. 1988;57-8, 62-4, 83-110, 133-45.
  21. Williams, C. M., & Galli, S. J. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med. 2000;192(3):455-62. https://doi.org/10.1084/jem.192.3.455
  22. Ptak, W., Geba, G. P., & Askenase, P. W. Initation of delayed-type hypersensitivity by low doses of monoclonal IgE antibody: Mediation by serotonin and inhibition by histamine. J Immunol. 1991;170:3929-36.
  23. manna S.K., Mukhopadhyay A., Aggrarwal B.B.: Leflunomide suppresses TNF-induced cellular responses:effects on NF-kappaB, activator protein-1,c-jun N-terminal protein kinase, and apoptosis. J Immunol. 2000;165(10):5962-9. https://doi.org/10.4049/jimmunol.165.10.5962
  24. Bokemeyer D, Sorokin A, Dunn MJ. Multiple intracellular MAP kinase signaling cascades. Kidney Int 1996;49:1187-98. https://doi.org/10.1038/ki.1996.172
  25. Simon C., Simon M., Vucelic G., Hicks M.J., Plinkert P.K., Zenner H.P.: The p38 SAPK pathway regulates the expression of themMP-9 collagenase via AP-1-dependent promotor activation. Exp Cell Res. Dec 10. 2001;271(2):344-55. https://doi.org/10.1006/excr.2001.5374
  26. Ip YT, Davis RJ.:Signal transduction by the c-Jun N-terminal kinase(JNK)-from inflammation to development. Curr Opin Cell Biol. 1988;10(2):205-19.
  27. Waetzig V, Czeloth K, Hidding U, Mielke K, Kanzow M, Brecht S, et al. c-Jun N-terminal kinases (JNKs) mediate proinflammatory actions of microglia. Glia 2005;50(3):235-46. https://doi.org/10.1002/glia.20173
  28. Regnier, C. H., Song, H. Y., Gao, X., Goeddel, D. V., Cao, Z., & Rothe, M. Identification and characterization of an Ikappa kinase. Cell. 1997;90:373-83. https://doi.org/10.1016/S0092-8674(00)80344-X
  29. Zandi, E., Rothwarf. D. M., Delhase, M., Hayakawa, M., & Karin, M. The IkappaB kinase complex(IKK) cntains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell. 1997;91:243-52. https://doi.org/10.1016/S0092-8674(00)80406-7
  30. Beg AA, Baldwin AS Jr. The I kappa B protein: multifunctional regulators of Rel/NF-kappa B transcription factor. Genes Dev. 1993;7(11):2064-70. https://doi.org/10.1101/gad.7.11.2064
  31. Palombella VJ, Rando OJ, Goldberg AL, and Maniatis T. The ubiquitinproteasome pathway is required for processing the NF-$\kappa$B1 precursor protein and the activation of NF-$\kappa$B. Cell. 1996;78(5):773-85.
  32. Baldwin, A. S. Jr. The transcription factor NF-$\kappa$B human disease. J Clin Ivest. 2000;107:3-6.
  33. Barnes, P. J., & Karin, M. Nuclear factor-$\kappa$B: a pivotal transcription factor in chronic inflammatory disease. N Engl J Med. 1997;336:1066-71. https://doi.org/10.1056/NEJM199704103361506
  34. 김수영, 송용선. 창출에 대한 문헌적 고찰. 한방재활의학회지. 1997;7(1):583-9.
  35. 한국생약학교수협의회. 한방약리학. 서울:정담. 1998:132-5.
  36. 이용성. 經藥分類典. 서울:정담출판사. 2002:18.
  37. 이상인, 안덕균, 신민교, 노승현, 이영종, 이선희. 한약임상응용. 서울:전통의학연구소. 1986:218-9.
  38. 강은미, 정창호, 심기환. 한국산 삽주의 기능성. 농산물저장유통학회지. 2001;8(1):86-91.
  39. Satoh K., Yasuda I., Ushiyama K., Akiyama K., Kano I. The effect of crude drugs using diuretic on horse kidney (Na+-K+)-adenosine triphosphatase. Yakugaku Zasshi. 1991;111(2):138-45. https://doi.org/10.1248/yakushi1947.111.2_138
  40. 김진기, 박경렬, 나의식. 삽주의 定量的 形質에 의한 변이분석. 한국자원식물학회지. 2002;15(1):36-42.
  41. Hye-Young Sung, Young-Sun Choi, Sung-Hee Cho, Hyang-Rim Lee and Sang-Woo Choi. Effect of Methanol Extract of Rubus Coreanus Miquel and Atractylodes Japonica Rhizome on Hepatic Toxicity and Immunomodulating Activity in Mice. Nutritional Sciences 2006;9(2):68-73.
  42. 유광원, 신광순. 창출 성분의 장관 면역 자극을 통한 골수세포 증식활동. 한국식품과학회지. 2001;115:135-41.
  43. 김수용. 蒼朮 추출액이 肥滿白鼠와 3T3-Li의 지방세포분화에 미치는 영향. 원광대학교 대학원. 1997.
  44. 조항영. 蒼朮 알칼로이드의 진정작용에 관한 연구. 생약학회지. 1974;5(3):159-66.
  45. Butler DM, Maini RN, Feldmann M, Brennan FM. Modulation ofproinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF- alpha antibody with the interrukin-1 receptor antagonist. Eur Cytokine Netw. 1996(4):225-30.
  46. Erchler WB, Keller ET. Age-associated increased interreukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med. 2000;51:245-70. https://doi.org/10.1146/annurev.med.51.1.245

Cited by

  1. 복합생약 HO-Series의 숙취개선 임상적 유용성 평가 vol.51, pp.4, 2011, https://doi.org/10.22889/kjp.2020.51.4.278